IU Health Goshen Center for Cancer Care
Our Approach to Lymphoma & Blood Cancer
Integrated Care for lymphoma and blood cancer Patients
At Indiana University Health Goshen Center for Cancer Care, we’ve created a comprehensive lymphoma and blood cancer treatment program committed to your overall health. It’s a commitment that reaches from your initial diagnosis to recovery and beyond.
Throughout treatment, we use an integrated approach to cancer care where physicians, dietitians, naturopathic oncologists and counselors all work together as a team. These specialists bring a number of disciplines – from leading-edge medical therapies and groundbreaking research to patient-specific clinical trials – to offer you the most complete care possible. Plus, you have access to a host of supportive services, including counselors, support groups and chaplains. Every day, this multidisciplinary team of specialists works together to share ideas and contribute to your individualized treatment plan. And in recovery, we teach you to maintain a healthier lifestyle to help prevent cancer from returning.
At IU Health Goshen Center for Cancer Care, we’ve created a place like no other. Working to heal you, not just treat your cancer.
The right diagnosis and treatment
For lymphoma and blood cancer, the wrong diagnosis could lead to ineffective treatment. We use the latest tools available to correctly diagnose your cancer and select the most effective treatment.
The most refined types of chemotherapy
We offer the latest chemotherapy treatments to help minimize side effects and reduce recovery time. Plus, you’ll have access to breakthrough treatments only available through our ongoing research and clinical trials.
About lymphoma and blood cancer
In 2009, an estimated 140,000 new cases of lymphoma and blood cancer were diagnosed, accounting for almost 10 percent of all new cancer cases in the United States. However, it is important to note that nearly 1 million people in the U.S. are either living with or are in remission from these cancers. More accurate diagnoses, newer agents and drug combinations, and better supportive care are all contributing to longer survival and even cures for people diagnosed with these cancers.